SANA CIK: 1770121

Sana Biotechnology, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
billions USD
FY21:
0.56
FY22:
0.44
FY23:
0.21
FY24:
0.16
FY25:
0.15
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.57
FY22:
0.38
FY23:
0.35
FY24:
0.34
FY25:
0.27
Total assets
Change from FY21 to FY25
billions USD
FY21:
1.13
FY22:
0.82
FY23:
0.57
FY24:
0.50
FY25:
0.42

Liabilities & Equity

(negative)
Change from FY21 to FY25
billions USD
FY21:
0.10
FY22:
0.11
FY23:
0.06
FY24:
0.05
FY25:
0.08
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.30
FY22:
0.21
FY23:
0.21
FY24:
0.21
FY25:
0.18
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.73
FY22:
0.50
FY23:
0.29
FY24:
0.25
FY25:
0.16
Total liabilities & equity
Change from FY21 to FY25
billions USD
FY21:
1.13
FY22:
0.82
FY23:
0.57
FY24:
0.50
FY25:
0.42

All amounts in billions USD Data source:SEC EDGAR